These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 25024746

  • 21. Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome.
    Zhang H, Legro RS, Zhang J, Zhang L, Chen X, Huang H, Casson PR, Schlaff WD, Diamond MP, Krawetz SA, Coutifaris C, Brzyski RG, Christman GM, Santoro N, Eisenberg E, Reproductive Medicine Network.
    Hum Reprod; 2010 Oct; 25(10):2612-21. PubMed ID: 20716558
    [Abstract] [Full Text] [Related]

  • 22. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B, Eijkemans MJ, de Jong FH, Payne NN, Bouchard P, Giudice LC, Fauser BC.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
    Kamenov Z, Kolarov G, Gateva A, Carlomagno G, Genazzani AD.
    Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Misso ML, Costello MF, Garrubba M, Wong J, Hart R, Rombauts L, Melder AM, Norman RJ, Teede HJ.
    Hum Reprod Update; 2013 Feb; 19(1):2-11. PubMed ID: 22956412
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome.
    Nemati M, Nemati S, Taheri AM, Heidari B.
    J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):579-585. PubMed ID: 28698075
    [Abstract] [Full Text] [Related]

  • 38. Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.
    El-Halawaty S, Rizk A, Kamal M, Aboulhassan M, Al-Sawah H, Noah O, Al-Inany H.
    Reprod Biomed Online; 2007 Nov; 15(5):495-9. PubMed ID: 18028738
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome.
    Verit FF.
    Gynecol Endocrinol; 2012 May; 28(5):365-9. PubMed ID: 22409701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.